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A product such as hydrated carbons (carbohydrates), lipids, proteins, and 
nucleic acids play significant roles in plants metabolically. But there are other 
natural organic products manufactured by plants, some of the products are com-
plex molecules, which are not primary metabolites. These biosynthetic products 
have possesses a variety of therapeutic merits in drug discovery. Some biosynthetic 
products show numerous appreciable therapeutic effects making them beneficial 
for trimming down polypharmacy and as viable candidates for the management 
of chronic diseases such as diabetes and hypertension in patients. The chapter 
discusses the pharmacological role of some biosynthetic products from plants and 
animals.
Keywords: alkaloids, phytosterols, biosynthesis, amino acids, pharmacological, 
terpenes
1. Introduction
Natural products are mostly produced by a living organism. A product such as 
carbohydrates, lipids, proteins, and nucleic acids play significantly impact on the 
primary role in in plants in terms of their metabolic reactions. Moreover, other 
natural organic compounds have also been known to be produced by plants, with 
which some of them are complex molecules, which are not primary metabolites. 
Different organisms may produce the same compounds through different pathways 
(e.g., convergent evolution), even if they are widely separated phylogenetically. 
The same organism may produce some compounds via over one biosynthetic path. 
There may be over one path available, such as in a changed linear process or meta-
bolic grid. Even if the same compound is present in two different organisms, they 
may be formed via different pathways. This, however, is more likely for metabolites 
with simple structures. It derives the major precursors from the metabolism of 
carbohydrate (sugars), protein (amino acids), and lipid (fatty acid). The pathway 
derived biosynthetically for aromatic amino acids is an integral source of aromatic 
compounds such as flavonoids, phenols, and some alkaloids. Glycolysis yields an 
important metabolite such as acetyl-CoA and also via the beta-oxidation of fatty 
acids and also used in the tricarboxylic acid cycle (TCA) in the manufacture of 
organic acids, which are also starting materials for secondary metabolites. Also, 
acetyl-CoA plays important role in synthesizing terpenes, which forms a distinct 
class of metabolites.
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2. Animal biosynthetic product
Animals contain many unique small molecules, including bioactive secondary 
metabolites. The compounds are protective, offensive or involved in communica-
tion [1]. Most of this product is also biologically effective, and they include the 
following.
2.1 Terpenes
Terpenes occur widely in nature. They are a large and varied class of hydrocar-
bons, which are produced by a wide variety of plants and by some animals. Terpenes 
are biosynthetically derived from isoprene units with the molecular formula C5H8. 
In bacteria and plants, isoprene precursor’s dimethylallyl pyrophosphate and 
isopentenyl pyrophosphate can be made either via the mevalonate or deoxyxylulose 
phosphate pathways, but in animals’ mevalonate is the source of these precursors 
[2]. The mevalonate pathway is the universal source of the terpenoid C5 precursor’s 
isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). In 
this pathway, three molecules of acetyl-CoA are condensed to 3-hydroxy-3-meth-
ylglutaryl-CoA with subsequent reduction to mevalonate, which is converted to 
IPP and DMAPP. Terpenes can exist as hydrocarbons or have oxygen-containing 
compounds such as hydroxyl, carboxyl, ketone, or aldehyde groups. After chemical 
modification of terpenes, it refers to the resulting compounds as terpenoids [3].
In the biochemical pathway of terpenoid synthesis, prenyltransferases take 
part in the condensation of activated forms of isoprene units. They link IPP with 
an isopentenyl diphosphate isomer of DMAPP in a “head-to-tail” manner. The 
linear chains of phenyl diphosphates that are formed in the reaction may also be 
changed through dimerization or cyclization by terpene synthase, forming terpe-
noids with new functions. They classify the resulting terpenes in order of size into 
hemiterpene, monoterpenes, sesquiterpenes, diterpene, triterpene, tetra terpenes, 
and polyterpenes. Hemiterpene comprises a single isoprene unit and changed into 
oxygen-containing derivatives called hemiterpenoids [3].
We have found terpenoids to be useful in the prevention and therapy of several 
diseases, including cancer, and also to have antimicrobial, antifungal, antiparasitic, 
antiviral, anti-allergenic, antispasmodic, antihyperglycemic, anti-inflammatory, 
and immunomodulatory properties [3].
2.2 Carnitine
Vaz and Wanders, [4] have described that carnitine plays a vital role in energy 
production in living organisms in terms of metabolism since it enables activated 
fatty acids to enter the mitochondria, where broken down via β-oxidation. 
Carnitine is present in all animal species, including other multiple micro-organisms 
and plants. They maintain its homoeostasis through endogenous synthesis, 
absorption from dietary sources and efficient tubular reabsorption by the kidney. 
Animal tissues contain relatively high amounts of carnitine, varying between 0.2 
and 6 μmol/g, with the highest concentrations in heart and skeletal muscle. Apart 
from the diet being the primary source of carnitine, most mammals can synthesize 
carnitine internally [4].
Carnitine synthesis is from two amino acids; precisely lysine and methionine. 
Lysine serves as the carbon backbone of carnitine and the 4-N-methyl groups 
emanate from methionine [5]. Proteins in mammals contain N’trimethyl-lysine 
(TML) residues. N-methylation of these lysine residues occurs as a post-trans-
lational event in proteins such as calmodulin, myosin, actin, cytochrome c and 
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histones. This reaction mostly catalysed by specific methyltransferase, which uses 
S-adenosylmethionine as a methyl donor. TML is the first metabolite of carnitine 
biosynthesis is released through the action of Lysosomal hydrolysis of these pro-
teins. TML is first hydroxylated on the 3-position by TML to yield 3-hydroxy TML 
(HTML). Aldolytic cleavage of HTML yields 4-trimethylaminobutyraldehyde 
(TMABA) and glycine, a reaction catalysed by HTML aldolase (HTMLA; EC 
4.1.2.‘X’). Dehydrogenation of TMABA by TMABA dehydrogenase (TMABA-DH; 
EC 1.2.1.47) results in the formation of 4-Ntrimethylaminobutyrate (butyrobeta-
ine). In the irrevocable step, butyrobetaine is hydroxylated on the 3-position by 
γ-butyrobetaine dioxygenase to yield carnitine [4]. Carnitine has an important role 
in the transport of activated long-chain fatty acids from the cytosol to the mito-
chondrial matrix where β-oxidation takes place. Second, they involve carnitine in 
transferring the products of peroxisomal β-oxidation, including acetyl-CoA, to the 
mitochondria for oxidation to CO2 and H2O in the Krebs cycle.
Pharmacologically, carnitine has possessed several effects on bone mass, male 
infertility, cognitive support, [6] metabolic function improvement, [7] neuropro-
tective effects in Alzheimer’s dementia [8] and Parkinson’s disease, [9] protection 
against oxidative stress damage, [10] congestive heart failure, hypertrophic heart 
disease, and peripheral arterial disease treatment [11]. They have also shown it to 
improve peripheral vasodilator activity [12].
From [13] the ability of an agent to control endothelial dysfunction is through 
upsetting the balance between the production of a vasodilator such as nitric oxide 
and vasoconstrictor, such as endothelin-1 substances in response to physical or 
chemical stimuli. This is because it is through that imbalance that leads to endothe-
lial dysfunction, which is one of the initial steps in atherogenesis [14]. They relate 
endothelial dysfunction to cardiovascular risk factors such as arterial hypertension, 
dyslipidemia, diabetes, and obesity [15, 16]. They have therefore investigated car-
nitine gas in rats’ models to cause an endothelium-dependent dilatation in arteries, 
since endothelial nitric oxide seemed to be the main mediator of vasodilatation [17]. 
For the cardioprotective ability of carnitine to serve as a cardioprotective agent, 
isolated rat working heart through different antioxidant mechanisms in most of the 
cases [18]. In terms of insulin resistance, this is where a 20 weeks treatment with 
carnitine in animal obese models resulted in a reduction in body weight, abdominal 
adiposity, plasmatic insulin, and liver triglyceride content [19]. Several, studies have 
been conducted on the antioxidant properties of carnitine and was due mainly to a 
reduction in both lipid peroxidation and free radical generation [20]. A decreased 
expression of inducible NO synthase and protein nitration, and inhibition of 
tubular necrosis and neutrophil infiltration in transplanted kidneys [21] . For 
antioxidant study [22] also revealed that carnitine and its derivatives fundamental 
mechanisms as participating in redox signalling that affects transcription factors 
(Nrf2, PPARα, NF-κB, etc.) and activating the vitagene network.
2.3 Pheromone
Pheromone plays a key role in sexual communication and reproduction in many 
insects such as the moth’s species. In some insects, the pheromone is biosynthesized 
and released by specialized sex pheromone glands (PGs) that are along the inter-
segmental membrane between the 8th and 9th abdominal segments of females. 
Although the general pathway of sex pheromone synthesis in most species has not 
been established and the molecular mechanisms remain poorly understood [23]. 
Although de novo synthesis is more prevalent in the species studied to date, there 
are multiple examples of pheromone components derived from host precursors. 
Sometimes, such as leucine, used as starting material for fatty-acid derived sex 
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pheromone biosynthesis by Holomelina spp. (Lepidoptera: Arctiidae), the putative 
plant-derived precursor is extensively elaborated by a typically de novo pathway. In 
other cases, it converts a highly elaborated host precursor to a pheromone component 
through a simple chemical transformation. While they originally reported the utiliza-
tion of host precursors for pheromone biosynthesis in some insects, subsequent 
studies showed that pheromone biosynthesis was only or partially de novo [23].
The analysis of different pheromone glands in different species has revealed 
the occurrence of unusual fatty acids that have been proposed as precursors of 
pheromone components. Many lepidopteran sex pheromones are produced by 
P-oxidation steps with desaturase systems. However, only a few studies have a 
combination of different fatty acyl intermediates been used to show experimentally 
a pheromone biosynthetic pathway [23].
From [24] sex pheromone biosynthesis in moths begins with a palmitic or stearic 
acid moiety that is synthesized de novo in the PG through modifications of the 
fatty acid biosynthetic pathway. Through a series of enzymatic reactions such as 
desaturation, chain-shortening reaction, reduction, acetylation, and oxidation, it 
then converts the palmitic or stearic acids to the final pheromone components in a 
step-wise manner. Therefore, different enzymes are likely to be involved in the dif-
ferent reactions, and to date, the genes encoding 4 different classes of enzymes that 
are essential for this pathway have been functionally identified desaturases (Des), 
fatty acid reductases (FARs), fatty acid transport proteins (FATPs), and acyl-CoA-
binding proteins (ACBPs) [24].
Pheromones, a chemical or blend of chemicals released by an organism that 
causes a specific behavioral or physiological reaction in one or more conspecific 
individuals are important mediators of communication for bacteria, plants, and 
animals in these environments. Pheromone systems of insects have proved to be 
some of the richest intellectual sources for the nascent science of chemical ecology 
the composite pheromones can be classed into six behaviorally functional groups: 
sex, aggregation, dispersal (spacing or epideictic), alarm, recruitment (trail), and 
maturation [24].
Pheromones are noted to function as opposite-sex attractants, same-sex repel-
lents, and mother-infant bonding attractants and as menstrual cycle modulators 
[25]. A review article by [26] concluded that pheromones have aphrodisiac activity.
2.4 Melanin
Melanin is an abundant biological pigment that is present in mammalian which 
is located in areas such as skin, hair, eyes, ears and the nervous system. Birds’ 
feathers, squid’s ink, insects, plants and many other biological systems have been 
also known to contain melanin. It classifies melanin into three groups: eumelanin, 
pheomelanin and allomelanins. We term nervous system melanins as neuromelanin. 
Eumelanin colours commonly present as black or brown in animals [27].
Amino acid tyrosine is needed in the production of melanin, but its actions 
are catalyzed enzymatically by tyrosinase. In their primary biosynthetic pathway, 
tyrosine is hydroxylated to form the catecholamine 3,4-dihydroxyphenylalanine 
(DOPA), which is then oxidized to form 3,4-dioxyphenylalanine (dopa quinone) 
before cyclization to 5,6-indole quinones and their subsequent polymerization to 
form melanin [27].
Mason-Raper pathway can also produce melanin, and it started by the usage of 
tyrosine to form dihydroxyphenylalanine by tyrosinase through an oxidation reaction. 
The product (dihydroxyphenylalanine) formed is then oxidized by the same enzyme 
to dopa quinone, which rearranges spontaneously to leuco dopa chrome and then to 
dopa chrome. An unusual trait of dopa chrome that of decolorizing slowly if held 
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under a vacuum allowed the identification of the subsequent intermediate 5,6-dihy-
droxy indole-2 carbolic acid, which loses its carboxyl group to become 5,6-dihydroxy 
dole. Upon exposure to air 5,6-dihydroxy indole is oxidized to indole 5,6-quinone and 
then to melano chrome, a purple compound that polymerizes to melanin [27].
Similar to the biosynthesis of eumelanin, melanin known as pheomelanin is 
biologically synthesized, except that it incorporates a precursor containing sulphur 
in the structure.
It has revealed melanin from natural sources to exhibit a broad spectrum of 
biological activities such as UV radiation protection, enzymatic lysis, and damage 
by oxidants, and resistance to drugs by pathogens, protection of insects against 
bacteria and antiviral protection. They have shown melanin to chelate metal ions 
and to act as a physiological redox buffer [27]. With this in mind, several studies 
have pharmacologically shown that melanin is indeed effective as an antioxidant, 
[28–30] Immunomodulatory and enhancement, [31–34] hepatoprotective, [35] 
anticarcinogenic effects, [36] and anti-inflammatory [37].
Studies conducted in Nigella sativa L. by [38, 39] which contains a lot of mela-
nin in its seeds had the potential of treating imbalanced cytokine production and 
unconcern cancer and other immunotherapies. This was possible because melanin 
induced TNF-alpha, IL-6 and VEGF mRNA expression.
Melanins from various sources exhibit significant antioxidant activity, melanin 
protects pigmented cells and adjacent tissues by adsorbing potentially harmful 
substances, which are then slowly released in nontoxic concentrations, Besides, 
melanin could also interact with orally administered drugs and a vehicle for drug 
delivery, Melanin extracted from different species of tea displays protective effects 
against hydrazine-induced liver injury, a remarkable anti-inflammatory effect of 
melanin has been reported [34].
2.5 Cholesterol
The most ubiquitous sterol in the animal system is present as cholesterol. But 
plant lack cholesterol notwithstanding, they contain structurally similar other 
sterol and similar biosynthetic pathway exist both in plants and animals and some 
prokaryotes. In humans, Normal healthy adults synthesize cholesterol at a rate of 
approximately 1 g/day and consume approximately 0.3 g/day. A relatively constant 
level of cholesterol in the body (150–200 mg/dL) is maintained primarily by 
controlling the level of de novo synthesis, which is partly regulated in part by the 
dietary intake of cholesterol [40].
Cholesterol is biosynthesized from a 2-carbon metabolic intermediate, acetyl-
CoA hooked end to end involving several enzymatic reactions and finally gets 
converted into the 27-carbon molecule of cholesterol. Metabolism (catabolism) of 
lipids, carbohydrates and proteins leads to the formation of AcetylCoA. The process 
of cholesterol synthesis has five major steps where the conversion of Acetyl-CoAs 
to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) is the first. HMG-CoA is con-
verted to mevalonate, followed by the formation of an isoprene-based molecule, 
isopentenyl pyrophosphate (IPP), with the concomitant loss of CO2 from mevalon-
ate. It, therefore, converts the IPP to squalene, where cholesterol is formed from 
squalene as the last step. The reaction is repeated with the units of Acetyl-CoA. 
Two moles of acetyl-CoA are condensed in a reversal of the thiolase reaction, 
forming acetoacetyl-CoA. Acetoacetyl-CoA and the third mole of acetyl-CoA are 
converted to HMG-CoA by the action of HMG-CoA synthase. HMG-CoA is con-
verted to mevalonate by HMG-CoA reductase, HMGR (it binds this enzyme in the 
endoplasmic reticulum, ER). HMGR requires NADPH as a cofactor, and two moles 
of NADPH are consumed during the conversion of HMG-CoA to mevalonate. 
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The reaction catalyzed by HMGR is the rate-limiting step of cholesterol biosyn-
thesis. Mevalonate is then activated by three successive phosphorylations, yielding 
5-pyrophosphomevalonate. Phosphorylation mevalonate and successive reactions 
maintain their solubility since otherwise, these are insoluble in water [40].
Cholesterol from both diet and synthesis is utilized in the formation of 
membranes and the synthesis of the steroid hormones and bile acids, regulating 
membrane fluidity and permeability as a cell membrane structural component, 
formatting lipid rafts with sphingolipid to mediate cell-to-cell recognition,  
adhesion, and communication [40].
3. Biosynthesis of plant origin
Different plants not only synthesize different aromatic secondary metabolites 
but also synthesize varying amounts of them at specific times and in specific 
subcellular compartments. One would expect that regulation of the differential 
biosynthesis of sometimes very complex molecular structures might involve regula-
tion of the supply of the precursors influencing the rate-limiting step for carbon 
flow through the shikimate pathway. Recent data on transgenic potatoes give some 
sign that this is indeed the case [41].
3.1 Biosynthesis of terpenoid compounds
Some terpenoids play an important role in plant growth and development, such 
as gibberellin, as plant hormones regulate plant development. Other terpenoids play 
a role in the interaction between plants and the environment, such as participating 
in plant defence systems as phytoalexins and interspecies competition as interspe-
cific sensing compounds. Terpenoids make up one of the largest and structurally 
diverse groups of naturally occurring compounds [42]. Mevalonic acid is mostly 
employed as a terpenoid synthetic racemate; however, mevalonic acid dimethoxy 
acetal may be resolved as its quinine salt. The acetates of the individual enantio-
mers of mevalonolactone are much less soluble than the racemate, and these may 
determine the purity and chirality of biosynthetic mevalonate. The steric course of 
many terpenoid biosynthetic processes has been followed using the stereospecifi-
cally deuterated and tritiated 2R,3R- [2-'H]-, 2S,3R- [2-3H]-, 3R,4R- [4–3 H] -, 
3R,4S- [4- HI-, and 3R,5R- [S 3 H]-mevalonate. Several routes for preparing 5S- 
[5-3H] mevalonate have been described. [l-3H] Isopentenal is a substrate for liver 
alcohol dehydrogenase and this affords 1 s- [l-3H] isopentenyl, which may then be 
converted into mevalonic acid. Alternatively, [5-3H] mevalonic acid can be reduced 
enzymatically with mevalonate reductase to afford 5S-[5-3H] mevalonic acid. The 
hemithioacetal of mevalonate and coenzyme-A is reduced by 3-hydroxy-3-methyl-
glutaryl COA reductase.” The steric course of this reduction is now known and they 
can also adapt this to afford 3R,5S- [5-3H] mevalonic acid. They have reported a 
mevalonate kinase assay [13]. An enzyme system capable of forming the mono- and 
pyro-phosphates of mevalonic acid, isopentenyl pyrophosphate and dimethylallyl 
pyrophosphate has been isolated ‘From orange-juice vesicles and shown to convert 
isopentenyl pyrophosphate and dimethylallyl pyrophosphate into linalool [42].
3.1.1 Pharmacology of terpenoids
Antitumour, [43] anti-inflammatory, antibacterial effects, cardiovascular 
effects, antimalarial, hypoglycemic effect, and transdermal absorption promotion 
have been investigated to give such pharmacological activities. Other activities apart 
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from the mentioned above include insect resistance, immunoregulation, anti-
oxidation, antiaging, and neuroprotection have also been known [3].
3.1.2 Works done on terpenoids
They have conducted several studies on terpenoids and their outcomes are 
promising. For antitumour activity, they have shown that perillyl alcohol which 
contains terpenoids plays a preventive and therapeutic role in cancer. The results 
showed that the administration of perillyl alcohol in rats can significantly reduce the 
incidence and multiplicity of colonic invasive adenocarcinoma caused by the injec-
tion of carcinogen azomethane [43]. Paeoniflorin which is a monoterpene glycoside 
compound isolated from the root of Paeonia lactiflora gave significant levels of 
anti-inflammatory activity. It could also dose-dependently inhibit the production 
of inflammatory factor nitric oxide (NO), interleukin-6 (IL-6) and tumour necrosis 
factor-alpha (TNF-α) induced by lipopolysaccharides (LPS) [44]. Besides, menthol, 
which is a cyclic monoterpene, has been shown to have antibacterial activity [45], 
they found that menthol showed significant inhibitory activity of biofilm when 
studying the effects of plant-derived terpenoids on Candida albicans. Several studies 
have also shown that terpenoids, particularly artemisinin which is a sesquiterpene 
lactone compound isolated from Artemisia annua Linn, has an effective antimalarial 
activity and currently in use [3]. The latest findings suggest that tanshinone IIA (TS) 
which is a terpenoid can prevent the formation of atherosclerosis and the damage 
and hypertrophy of the heart. This is because of its ability to inhibit the oxidation of 
low-density lipoprotein and the expression of proinflammatory factors, and TS also 
has certain activity and potential to stabilize atherosclerotic plaque [46].
3.2 Biosynthesis of pinocembrin
In plant propolis, pinocembrin is one of the most abundant flavonoid, and it could 
also be commonly found in a most plants. Biological synthesis plays a significant part 
in synthesizing pinocembrin owing to its increased yield and low cost in production. 
They can extract pinocembrin from product of nature but that methodology is of 
high production cost and reduced yield. Biological synthesis from microorganisms 
features the advantages of low cost and large product yield, which compensate for the 
lack pinocembrin natural sources [47]. Escherichia coli has been known to be used in 
the production of pinocembrin. Recently, efficient way of producing pinocembrin 
has been the main goal of most researchers. Biological production of pinocembrin 
mostly requires that one needs to supplement an expensive phenylpropanoid starting 
materials, resenting a key problem in previous studies. Genetic engineering is now 
the breakthrough in the synthesis of pinocembrin biosynthesis, where there is the 
usage of bacteria to construct the synthesis of pinocembrin from glucose. To manu-
facture the flavonoid precursor (2S)-pinocembrin directly from glucose, four-vectors 
have been assembled, 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase, 
chorismite mutase/pre-phenate dehydratase, phenylalanine ammonia-lyase (PAL), 
4-coumarate: CoA ligase (4CL), chalcone synthase (CHS), chalcone isomerase 
(CHI), malonate synthetase, malonate dehydratase, and malonate carrier protein. 
Pinocembrin synthesis from glucose can be achieved through adjustment of other 
corresponding parameters in the synthetic pathways [47].
3.2.1 Pharmacological activities
Pharmacologically, pinocembrin can exhibit anti-inflammatory, [48] antioxi-
dant, [49] antibacterial [50] and neuroprotective activities [51]. They mainly use 
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Pinocembrin for the treatment of ischemic stroke. Moreover, current studies have 
shown that pinocembrin may have an effect of reversing Parkinson’s disease (PD) and 
Alzheimer’s disease (AD) in affected patients [52]. It has also been shown to exhibit 
anti-pulmonary fibrosis and vasodilating effects. Pinocembrin undergoes several 
pathways to perform its pharmacological effects. In addition, pinocembrin could 
also ease blood brain barrier (BBB) disruption and neurological injury by interfering 
and reducing the levels of inflammatory factors and reactive oxygen species (ROS). 
Also, pinocembrin is known to preserve mitochondrial integrity via the activation of 
the signal-regulated kinase/nuclear factor erythroid 2-related factor 2 (Erk1/2-Nrf2) 
pathway extracellularly [53]. Pinocembrin also attenuates apoptosis by affecting the 
p53 pathway, influencing the Bax-Bcl-2 ratio and cytochrome C release [54].
3.2.2 Works done on pinocembrin
The brain of rats has been demonstrated to be protected against apoptosis and 
oxidation induced by ischemia–reperfusion both in vivo and in vitro. Pinocembrin 
attenuates blood–brain barrier injury induced by global cerebral ischemia–reperfu-
sion in rats [55]. Further research work is also showing that Pinocembrin has the 
potential of giving positive outcomes in the treatment of ischemic stroke. This is 
because it can significantly cause a reduction in the regions of cerebral infarction 
in rats and cerebral ischemia and reduce the level of cerebral oedema and apoptosis 
of the cells in the nerve [47]. Shen et al., [47] concluded that pinocembrin exhibits 
several effects on, Parkinson’s disease, ischemic stroke, solid tumors, Alzheimer’s 
disease, and some other diseases because of possibility of releasing inflamma-
tory factors by halting several signaling pathways, such as PI3K/AKT and MAPK. 
Antioxidant role is also known in pinocembrin because of its ability to reduce the 
release of NO, nNOS, ROS and iNOS.
3.3 Biosynthesis of polyphenols
Polyphenols constitute an integral class of key secondary metabolites with 
multiple phenolic hydroxyl groups including flavonoids, stilbenes, phenolic acids, 
and tannins (hydrolysable and condensed) [56] synthesized mainly by a metabolic 
pathway termed phenylpropanoid [57].
The biological synthetic routes of polyphenols involve the phenylpropanoid 
and shikimic acid metabolism pathways [58]. In Salvia species, polyphenols found 
are mainly reduced by the phenylpropanoid metabolic pathway [57–60] and most 
derivatives have synonymous basic structures [61].
Tyrosine and Phenylalanine are precursor compounds of the phenylpropanoid 
metabolic pathway, and their biosynthetic pathways make up two (2) parallel 
branches of this pathway involving five rate-limiting enzymes [62, 63]. These 
enzymes consist of phenylalanine ammonia-lyase (PAL); which is a key regulatory 
enzyme in plant metabolism, cinnamic acid-4-hydroxylase (C4H) and 4-couma-
rate: coenzyme A (COA) ligase (a peculiar regulatory enzyme in the phenylalanine 
branch), rosmarinic acid synthase (a key enzyme in catalytic synthesis) and tyro-
sine aminotransferase (the initial key enzyme and rate-limiting enzyme in tyrosine 
metabolism pathway), [64].
Caffeic acid derivatives are phenolic acids derived from Salvia species which are 
mostly produced via esterification of caffeic acid with danshensu [65, 66]. Caffeic 
acid originates from the class of phenyl propionic acid, [67] and it is the fundamen-
tal structural unit of phenolic acids [68]. Phenylalanine is the precursor compound 
of caffeic acid, which helps in the production of caffeic acid through the action of 
C4H and PAL enzymes.
9
Pharmacological Role of Biosynthetic Products
DOI: http://dx.doi.org/10.5772/intechopen.96977
It plays a key role in the metabolic pathway of phenylpropanoid and is a 
precursor compound of rosmarinic acid [69, 70]. Studies have speculated that, 
catalysis of caffeoyl CoA in the main synthetic route of rosmarinic acid, caffeic 
acid. Subsequently, caffeoyl CoA and 4-hydroxyphenyl acetic acid is catalysed by 
hydroxycinnamoyl-CoA: hydroxyphenyllactate hydroxycinnamoyl transferase 
(rosmarinic acid synthase (RAS)) to earn caffeoyl-40-hydroxy phenylacetic acid 
(caffeoyl-40-HPLA).
The reaction is finally catalyzed by CYP98A14 to rosmarinic acid [71]. 
Rosmarinic acid is employed in the formation of Salvianolic acid E under the action 
of enzymes and other reactions which are then transformed into salvianolic acid 
B and other compounds. This observation seeks to infer that rosmarinic acid is the 
core constituent unit of a series of complex phenolic acids, such as salvianolic acids 
[72, 73]. Complex phenolic compounds formation is based mostly on rosmarinic 
acid synthesis [61].
The phenylpropanoid metabolic pathway is an important upstream pathway for 
producing flavonoids such as anthocyanins, isoflavonoids, and flavonoids [74].
3.3.1 Pharmacology of polyphenols
They exhibit numerous pharmacological activities, such as anti-cardiovascular, 
[75] anti-oxidation [76], anti-tumor [77] anti-inflammatory [78]. Other pharma-
cological activities exhibited by polyphenols include; anti-hypertensive (caffeic 
acid, chlorogenic acid and salvianolic acid A), memory and cognitive impairment 
improvement (rosmarinic acid, total salvianolic acid), hypoglycemic (Salvianolic 
acid B), antiviral (Protocatechuic aldehyde, Magnesium lithospermate B, rosmaric 
acid), prevents and treats cancer (Danshensu, Protocatechualdehyde) [79].
3.3.2 Works done on polyphenols
Chang et al., [80] have illustrated that phenolic acids exhibit better antioxidant 
properties because of their mechanism of action including, inhibition of free radical 
generation, free radical scavenging and lipid peroxidation. A study showed that 
rosmarinic acid, danshensu and caffeic acid were as effective as the positive control 
(quercetin), which scavenged 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals in 
a concentration-dependent way. On the other hand, ferulic acid was less effective 
[81]. Other studies have shown that danshensu and salvianolic acid B showed 
greater scavenging activities against HO·, −, DPPH, O2-, and 2,20-and-bis (3-eth-
ylbenzothiazoline-6-sulphonic acid (ABTS) than the other constituents. Among 
them, the half-maximal inhibitory concentration (IC50) of salvianolic acid B and 
danshensu were not significantly different, and there was no obvious difference in 
the scavenging actions of hydroxyl radicals [82]. Thus, hydroxyl radical scavengers 
are phenolic acids are.
Studies on inhibition of spontaneous lipid peroxidation in liver tissue of poly-
phenols in mice lead to the formation to the following order after testing all the 
seven polyphenols. Rosmarinic emerged the most efficacious followed by caffeic 
acid, protocatechuic aldehyde, chlorogenic acid, ferulic acid, and danshensu. 
3-hydroxycinnamic acid was studied in hydrogen peroxide -induced liver lipid per-
oxidation in rodents’ model. Also, other in vitro studies confirmed the antioxidants 
effects of these phenolic acids [83].
Salvianolic acid B was found to be effective in the reduction of myocardial 
ischemia–reperfusion injury. Ischemia–reperfusion model was established by 
ligating the left circumflex artery in Sprague–Dawley (SD) rats against myocar-
dial ischemia–reperfusion injury and the concentration and apoptotic index of 
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the plasma level of myocardial enzymes (cardiac troponins (CTn) I and creatine 
kinase-MB (CKMB)), endothelin (ET), superoxide dismutase (SOD), nitric oxide 
(NO), malondialdehyde (MDA), and histological changes of the heart were deter-
mined. The outcome was observed that salvianolic acid B significantly increased 
the plasma levels of CTn I, CKMB, MDA, and ET contents; decrease in T-SOD and 
NO contents; reduction in infarct size; and improved myocardial ultrastructure. 
It was concluded that salvianolic acid B has an impact against conditions such as 
myocardial ischemia–reperfusion injury via the regulation of reducing oxida-
tive stress, active oxygen metabolism, and myocardial apoptosis [84]. A study 
conducted by [85] also stated that salvianolic acid which is a phenolic could 
also be effective in alleviating ischemic-reperfusion injury. It could also prevent 
myocardial ischemia–reperfusion injury through an increased glucose condi-
tion by adjusting the NADPH oxidase 2 (Nox2)/reactive oxygen species (ROS)/
phosphorylated-c-Jun N-terminal kinase 2 (p-JNK2)/NF-κB pathway to reduce 
transient receptor potential cation channel, member 6 (TRPC6)/Ca2+ influx, 
subfamily C [86].
Anti-thrombotic effects which are through its actions on blood rheology has 
also been known to be a possible action of salvianolic acid in S. miltiorrhiza. It also 
acts as to prevent platelet aggregation by targeting P2Y1 or P2Y12 receptors, which 
are novel target receptors required for anti-platelet aggregation. Salvianolic acid 
B experimentally, only antagonizes the action of platelet P2Y12 receptors, while 
salvianolic acid A and C are P2Y12 and P2Y1 receptor inhibitors [87].
Other studies by [88] have also illustrated that caffeic acid can inhibit platelet-
mediated thrombosis by P-selectin expression, repression of ADP-induced platelet 
aggregation, ATP release, and Ca2+ mobilization and attenuate the activation of 
ERK, p38, JNK, and integrin αIIbβ3. It could also increase cAMP expression levels.
Better antiplatelet and anti-thrombotic therapeutic efficacy have also been 
demonstrated in Danshensu when compared to other constituents. Several con-
tributions have been made through its ability to selectively suppress balancing 
the ratio of thromboxane A2 (TXA2)/prostacyclin (PGI2) and the expression of 
cyclooxygenase (COX)-2 [89].
Several studies have been conducted on the anti-liver injury activity of 
polyphenols and from [90] salvianolic acid B protects liver cells by enhancing 
lysosome-associated membrane protein 1 (LAMP1) expression and preserving 
lysosomal membrane integrity through scavenging ROS. Salvianolic A has also 
been concluded by [91, 92] that it protects acute hepatic injury after inducing mice 
models with concanavalin A. The outcome of the liver function markers, alanine 
aminotransferase (ALT) and serum aspartate aminotransferase (AST) showed 
that salvianolic acid A significantly reduced ConA-induced AST and ALT activity. 
Also, there was a reduction in the hepatotoxic cytokine levels, such as interferon 
(IFN)-γ and tumor necrosis factor (TNF)-α; improvement in the increased NF-κB 
level and cleaved caspase-3; and reversal of B-cell lymphoma-extra-large (Bcl-xL) 
expression [79].
Wang et al. [90] concluded that salvianolic acid B seems to be effective and 
safe, and it could develop this natural component into a potential therapeutic 
agent for the management of glioma. This is because of its inhibitory actions on the 
human glioma U80 cells, which its initiation leads to p38-activation-mediated ROS 
production.
Reviews conducted by Rasouli et al. [93] throws more light on the importance of 
polyphenols from foods. This because they are beneficial in most health conditions 
including pernicious human diseases (HDs). Also, people who followed a specific 
diet particularly polyphenol-rich diets are of lower risk of several ranges of chronic 
diseases, such as diabetes, obesity, cancer, and heart disease.
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3.4 Biosynthesis of berberine
Berberine is a quaternary ammonium salt and it’s from a group of isoquinoline 
alkaloids termed 2,3–methylenedioxy-9,10-dimethoxyprotoberberine chloride; 
C20H18NO4+. It is highly concentrated in the roots, stem bark, rhizomes and of 
numerous plants including Rhizoma coptidis, Tinospora cordifolia, Coptis chinensis,  
Hydrastis canadensis, Berberis vulgaris, Berberis aquifolium, Berberis aristata, 
Arcangelisia flava and Cortex rhellodendri [94].
Berberine comprises of several derivatives such as berberrubine, jatrorrhizine 
thalifendine, and demethyleneberberine [94].
3.4.1 Pharmacological activity
Pharmacologically, almost all parts of the plant have been shown to have several 
properties. These pharmacological properties of berberine includes antiemetic, 
antipyretic, tonic, antimicrobial, antipruritic, antiarrhythmic, sedative, antioxidant, 
anti-inflammatory, hypotensive, antinociceptive, anticholinergic and cholagogue 
actions, and it has been used sometimes like dysentery cholecystitis, cholelithiasis, 
leishmaniasis, jaundice, malaria and gall stones [95]. Berberine has been used 
for treating diarrhoea and gastrointestinal disorders for a long time [96, 97]. It 
has multiple pharmacological effects including; antimicrobial activity against 54 
microorganisms, [98] inhibition of intestinal ion secretion and smooth muscle 
contraction, inhibition of ventricular tachyarrhythmia, reduction of inflammation, 
stimulation of bile secretion and bilirubin discharge [99]. Moreover, [100] have 
reviewed that berberine to possess pharmacological activities such as insulin secre-
tion promotion, insulin resistance reduction, increased insulin secretion, inhibiting 
gluconeogenesis in the liver, stimulating glycolysis in peripheral tissue cells, reducing 
intestinal absorption of glucose, and regulating lipid metabolism, and modulat-
ing gut microbiota. Also, it is significant in the treatment of diabetic nephropathy, 
diabetic neuropathy, and diabetic cardiomyopathy because of its anti-inflammatory 
and antioxidant activities, in inflammatory diseases.
3.4.2 Works done on berberine
Antidiabetic activity of berberine has been conducted by Pang et al., [101] 
His review article highlighted several mechanisms with which berberine act to 
improve glucose control. A bibliometric review conducted between 1985–2018 also 
outlines that berberine has significant antibacterial and antipyretic effects and is a 
commonly used drug for treating infectious diarrhoea and amoebiasis. Berberine 
has significant antipyretic and antibacterial effects and its commonly used for the 
treatment of diarrhea associated with infections.
Zhao et al., [102] also added., that berberine has an improved activity in improv-
ing nonalcoholic fatty liver disease by halting glucogenesis and comprehensively 
regulating lipid metabolism, and its effect on inhibiting lipogenesis in the liver was 
much stronger. He also suggested that weight loss may partly mediate the improve-
ment and would be a drug of choice for NAFLD patients and glucose metabolic 
disorder. But they, therefore, require future clinical trials to confirm these effects.
The review article by Zhu et al., [103] threw more light on the mechanism of 
action of berberine. It was stated that berberine potentially works through an 
increase in insulin sensitivity, LDLR mRNA stabilization, improvement of mito-
chondrial function, regulation of adenosine monophosphate-activated protein 
kinase (AMPK) pathway, alleviation of oxidative stress, and regulation of gut 
microenvironment being the major targets of berberine in the treatment of NAFLD. 
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Also, the reduction of DNA methylation and that of proprotein convertase subtili-
sin/Kexin 9 (PCSK9) expression is also involved in the pharmacological mecha-
nisms of berberine involved in the management of NAFLD. Several mechanisms 
such as the immunologic mechanism in relation to the treatment of NAFLD, drug 
combinations, development of berberine derivative, delivery routes, and drug dose 
can be considered for further research.
From Cicero and Baggioni, [104] a good deal of preclinical evidence supports the 
role of berberine in the management of cerebral ischemia, Alzheimer’s disease, anxi-
ety, mental depression, and schizophrenia. However, most of these data have been 
obtained purely through experimental models [105]. Of particular interest is the 
potential antidepressant activity of berberine, it was found to inhibit the immobility 
time in mice in both tail suspension test and forced swim test. These two antidepres-
sant models all gave effects in a dose-independent manner [106]. Regarding the 
bioactivities of berberine reported, monoamine oxidase (MAO)-A activity is noted 
to be inhibited. From Kong et al., [107] (MAO)-A is an enzyme needed to catalyze 
the deamination of catecholamines oxidatively, and thus inhibiting degradation 
of these neurotransmitters. Levels of norepinephrine, serotonin and dopamine, 
neurotransmitters are increased due to induction by MAO-A enzyme after acute and 
chronic administration of berberine in mice [107]. Under Kulkarni and colleague’s 
data, Arora and Chopra [106] revealed the protective antidepressant-like activity of 
berberine against the reserpine-induced biogenic amine depletion (a monoamine 
depletion) mostly employed in the induction of depression in animals.
However, to there is therefore no conclusive data on the evaluation of the poten-
tial antidepressant effects of berberine in higher mammals such as humans [108].
The review article by Td et al., [100] has shown that berberine has the potential 
of reversing neurodegenerative effects in diseases such as Alzheimer, Huntington’s 
disease, Parkinson’s and because of its antioxidant activity. They have also conducted 
antiviral activity on berberine by Warowicka et al., [94] and he observed berberine 
could regulate the MPK/mTOR, MEK–ERK, and NF-κB signaling routes, which are 
needed for viral replication. It is deduced that it provides adequate supports to the 
host immune response, thus leading to viral clearance. Berberine and its derivatives 
might promise agents to be considered in future in the fight against the recent pan-
demic SARS-CoV-2, which is the causative agent responsible for causing COVID-19.
3.5 Biosynthesis of aristolochic acid
Roots and rhizomes of most Aristolochia species contain mixtures of nitro 
phenanthrene-carboxylic acids. The key acid is the aristolochic acid I. The aristolo-
chic acids; a group of substituted 10-nitro-1-phenanthrene acids have been known 
to occur in most species of the genus Aristolochia, and other members of the family 
Aristolochiaceae [109, 110]. Aristolochic acids emanate from aporphines through 
oxidative cleavage of the hetero ring. They stated that the results were consistent with 
the observation that the aristolochic acids rises from aporphines via oxidative cleav-
age of the hetero ring. Because the pathway from tyrosine to the product runs through 
dopa, which is an amino acid that undergoes reversible transamination in plants [111].
In all cases, aristolochic acid I and the structurally related alkaloid magnoflorine 
could be shown in the roots and rhizomes. The biogenetic relationship with the 
aporphine alkaloids was due to both the structure of aristolochic acid and its occur-
rence with magnoflorine. Aporphine skeleton could yield aristolochic acids through 
oxidative cleavage of the heterocyclic ring. Benzylisoquinoline norlaudanosoline is 
a key intermediate in the biosynthetic pathway, which can be formed from tyrosine 
or a biochemical equivalent. Aporphine skeleton is also produced from norlaudano-
soline through the phenol oxidation and dienol-benzene rearrangement [110].
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Aristolochiaceae family of plants produces aporphine alkaloid, 4,5- 
dioxoaporphine, which is referred to as possible intermediates of the precursors 
of aristolochic acids and aristo lactams [112].
3.5.1 Pharmacological activities of aristolochic acid
It has been reported by Okhale et al., [112] that Aristolochic acid antirheumat-
ics, as diuretics, in the treatment of oedema, to facilitate childbirth, in wound 
healing and for less common conditions such as cough, hemorrhoids, and asthma. 
Aristolochic acids also possess antibacterial [113, 114] antifungal, antiviral, and 
antitumor effects and in more recently, have been used in the pharmaceutical 
industry as convention usage [115, 116]. Herbal preparations with active constitu-
ents being aristolochic acids have been used for different illnesses such as urinary 
tract infection, hepatitis, vaginitis, oedema, upper respiratory tract infection, 
eczema, bronchitis, headache, oral ulcer, neuralgia, dysmenorrhea, arthralgia, 
hypertension, cerebrovascular accident, heart failure and pneumonia [117].
3.5.2 Works done on aristolochic acid
Aristolochia species that contain aristolochic acid is Aristolochia triangularis. 
Oliveira et al., [118] had revealed several studies such as the antiproliferative effect, 
and his conclusions show its outcomes are very desirable.
Several studies have reported that aristolochic acid is the potential of causing 
carcinogenic effects in humans [119]. Nephrotoxic effects of the renal cortex and 
further damage to the liver and bladder when much of it is ingested; likely because 
of the formation of bulky chemical DNA adducts. AA is dA-AA formation is the 
most abundant and mutagenic form of DNA adduct associated with. In exons 2–11 
of TP53, mutation results from bulky chemical DNA adducts, primarily of A: T base 
pairs [120, 121] have also conducted potential nephrotoxic effects of aristolochic 
acids and also proposed possible molecular mechanism of such effect. This is 
through induction of oxidative/nitros active stress and mitochondrial dysfunction, 
apoptosis induction, inflammatory responses induction, and fibrosis. A pharma-
cokinetic study conducted by [122] also added up that Aristolochic nephrotoxicity 
comprises dose-dependent and progressive tubular damage, even though significant 
changes in the morphology of glomeruli was not seen.
3.6 Biosynthesis of canthaxanthin
Canthaxanthin is a carotenoid, and it’s one class identified to possess a lot of colou-
ration. Canthaxanthin is biologically synthesized from the precursor, β-carotene, 
ketolase enzyme (BKT in algae and CRTW in bacteria) serves as the enzyme for the 
reaction. The allylic 4-position to a carbonyl group is oxidized in the β-ring, producing 
echinenone as intermediate product. The same enzyme sequentially transforms the 
40-carbon atom in the second β-ring to a carbonyl [123, 124]. This is also a substrate 
for the synthesis of another keto carotenoid astaxanthin which is of commercial inter-
est. The enzyme β-carotene hydroxylase introduces hydroxyl (OH) groups into the 
canthaxanthin rings at positions 3,30, resulting in astaxanthin formation [125].
3.6.1 Pharmacological activities of canthaxanthin
Antioxidant and free radical scavenging properties [125]. Canthaxanthin alters 
the onset of many diseases such as cataracts, atherosclerosis, multiple sclerosis, 
age-related macular degeneration, and cancer [126].
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3.6.2 Works done on canthaxanthin
Studies have shown that canthaxanthin show significantly higher free radical 
scavenging and antioxidant properties than other xanthophylls and carotenes, and 
they can also scavenge reactive oxygen species and quench singlet oxygen. Also, it 
has been revealed in in vivo experiments that the supplementation of canthaxanthin 
led to a significant decrease in lipid peroxidation to preventing induced rats liver 
DNA damage [126]. They have also found it in cell detoxification of lipopolysaccha-
rides. With respect to uses of canthaxanthin in humans, less comprehensive studies 
have been conducted to elucidate its effects and safety. It is popularly employed as 
natural skin-tanning agent, and cosmetics (Figure 1).
4. Conclusion
It employs most of these bioactive products in complementary medicine, and 
others are under clinical study. They can source bioactive products from plants, 
animal and some micro-organisms. They are produced mostly via a sequence of 
physiological processes or synthesized exogenously. Many biosynthetic products 
exhibit one therapeutic effect. These several biosynthetic metabolites have 
many pharmacological effects, thus making them useful candidates for drug 
discovery.
Figure 1. 
A summary of biological activities and health-promoting properties of biological metabolite.
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